Browse by author
Lookup NU author(s): Dr Declan Gray
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Despite efforts to develop new antibiotics, antibacterial resistance still develops too fast for drug discovery to keep pace. Often, resistance against a new drug develops even before it reaches the market. This continued resistance crisis has demonstrated that resistance to antibiotics with single protein targets develops too rapidly to be sustainable. Most successful long-established antibiotics target more than one molecule or possess targets, which are encoded by multiple genes. This realization has motivated a change in antibiotic development toward drug candidates with multiple targets. Some mechanisms of action presuppose multiple targets or at least multiple effects, such as targeting the cytoplasmic membrane or the carrier molecule bactoprenol phosphate and are therefore particularly promising. Moreover, combination therapy approaches are being developed to break antibiotic resistance or to sensitize bacteria to antibiotic action. In this Review, we provide an overview of antibacterial multitarget approaches and the mechanisms behind them.
Author(s): Gray DA, Wenzel M
Publication type: Article
Publication status: Published
Journal: ACS Infectious Diseases
Print publication date: 12/06/2020
Online publication date: 10/03/2020
Acceptance date: 01/01/2020
Date deposited: 25/06/2020
ISSN (electronic): 2373-8227
Publisher: American Chemical Society
PubMed id: 32156116
Altmetrics provided by Altmetric